Skip to Main Content

Author Details

Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
2001
123
40
PMIDPaper TitleJournal TitlePublished Year
36016484Comparison of the long-term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation.Cancer Med2023
35802197Triple therapy in biliary tract cancers: GemOX plus immune checkpoint inhibitor in combination with lenvatinib or NGS-guided targeted therapy.J Cancer Res Clin Oncol2023
37424821Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study.Am J Cancer Res2023
34880159Elevated serum CA19-9 indicates severe liver inflammation and worse survival after curative resection in hepatitis B-related hepatocellular carcinoma.Biosci Trends2022
35755313TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer.Int J Endocrinol2022
35903683CNN1 Represses Bladder Cancer Progression and Metabolic Reprogramming by Modulating HIF-1α Signaling Pathway.Front Oncol2022
36319978Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.BMC Cancer2022
35221916Circulating MicroRNAs From Plasma Small Extracellular Vesicles as Potential Diagnostic Biomarkers in Pediatric Epilepsy and Drug-Resistant Epilepsy.Front Mol Neurosci2022
32936899Inhibition of BRAF Sensitizes Thyroid Carcinoma to Immunotherapy by Enhancing tsMHCII-mediated Immune Recognition.J Clin Endocrinol Metab2021
33795650LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma.Cell Death Dis2021
33833794Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection.Gastroenterol Res Pract2021
35004960Adjuvant therapy for intrahepatic carcinoma after surgical resection: chemotherapy and future perspectives.Hepatobiliary Surg Nutr2021
34930913Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women.Cell Discov2021
33947843Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer.Cell Death Dis2021
33365080High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma.Oncol Lett2021
33095329Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers.Cancer Immunol Immunother2021
32157720Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.FASEB J2020
32091408Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.Aging (Albany NY)2020
33145266Apatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial.Ann Transl Med2020
32830166Systemic treatment of advanced or recurrent biliary tract cancer.Biosci Trends2020
32120023IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma.Cancer Lett2020
32528084Diagnostic evaluation of a deep learning model for optical diagnosis of colorectal cancer.Nat Commun2020
32362568Tumor specific methylome in Chinese high-grade serous ovarian cancer characterized by gene expression profile and tumor genotype.Gynecol Oncol2020
32322636Data analysis of PD-1 antibody in the treatment of melanoma patients.Data Brief2020
32371982The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway.Cell Death Dis2020
32293336Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.BMC Cancer2020
30583848Diagnosis of thyroid cancer using deep convolutional neural network models applied to sonographic images: a retrospective, multicohort, diagnostic study.Lancet Oncol2019
30842055Deep convolutional neural network models for the diagnosis of thyroid cancer - Authors' reply.Lancet Oncol2019
31092619Editor's Note: Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment.Clin Cancer Res2019
31112531Modified Pancreatojejunostomy in Pancreaticoduodenectomy for the Treatment of Periampullary Tumor: 8 Years of Surgical Experience.Med Sci Monit2019
30844035Tumor Mutation Load and Frequently Mutated Genes in Gastric Cancer-In Reply.JAMA Oncol2019
29216340Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?Ann Oncol2018
29860761[The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].Zhonghua Zhong Liu Za Zhi2018
29887251Long-term quality of life measured by the University of Washington QoL questionnaire (version 4) in patients with oral cancer treated with or without reconstruction with a microvascular free flap.Br J Oral Maxillofac Surg2018
30098163Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.JAMA Oncol2018
30176876Histone deacetylase 6 in cancer.J Hematol Oncol2018
30293396[Oncological safety and prognosis factors analysis of immediate breast reconstruction after nipple-areola-complex sparing mastectomy].Zhonghua Zhong Liu Za Zhi2018
29545971Modified Blumgart anastomosis without pancreatic duct-to-jejunum mucosa anastomosis for pancreatoduodenectomy: a feasible and safe novel technique.Cancer Biol Med2018
29351612A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.Ann Oncol2018
27888623Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.Oncotarget2017
28387999Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.Cancer Sci2017
28160565Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation.Oncotarget2017
28104028[Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis].Zhonghua Zhong Liu Za Zhi2017
28102193Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression.Nat Commun2017
28475000Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo.Tumour Biol2017
28123523Different but synergistic effects of bone marrow-derived VEGFR2<sup>+</sup> and VEGFR2<sup>-</sup>CD45<sup>+</sup> cells during hepatocellular carcinoma progression.Oncol Lett2017
28121485MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway.Autophagy2017
29423076Androgen receptor/let-7a signaling regulates breast tumor-initiating cells.Oncotarget2017
28535656[The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].Zhonghua Zhong Liu Za Zhi2017
28693138Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery.Oncol Lett2017
  • 1 - 50 of 123

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Jongmin Sim
Korea University Anam Hospital, Korea University College of Medicine
Career Start Year 2012
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 1
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
Yin Guan
DHC Technologies Co. Ltd.
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Li Liu
College of Big Data & Software Engineering, Chongqing University
Career Start Year 2005
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Karin Jirstr??m
Lund University
Career Start Year 2003
Number of shared co-authors 0
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 1
Yongwei Yu
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 1
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 3
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 2
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 19
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Co-authored papers 17
Qingyi Wei
South China University of Technology
Co-authored papers 11
Da Yang
Co-authored papers 10
Limei Hu
Aier Eye Hospital of Wuhan University
Co-authored papers 9
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Co-authored papers 8
David Cogdell
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Raphael E Pollock
James Cancer Center, The Ohio State University
Co-authored papers 3
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 3
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Yingmei Wang
Tianjin Medical University General Hospital
Co-authored papers 2
Chunlei Wu
The Scripps Research Institute
Co-authored papers 1
James A Eddy
Benaroya Research Institute at Virginia Mason, Institute for Systems Biology, Sage Bionetworks, University of Illinois at Urbana-Champaign
Co-authored papers 1
Scott D Patterson
Co-authored papers 1
Jun Wang
Zhongnan Hospital of Wuhan University
Co-authored papers 1
Lance D Miller
Co-authored papers 1
Umit Topaloglu
Wake Forest School of Medicine
Co-authored papers 1
William F Symmans
Co-authored papers 1
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 1
Daniel J Brat
Co-authored papers 1
Ilya Shmulevich
Institute for Systems Biology
Co-authored papers 1
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Co-authored papers 1
Matti Annala
University of British Columbia
Co-authored papers 1
Christoph Reinhard
Lilly Research Laboratories
Co-authored papers 1
Paul S Mischel
Stanford University
Co-authored papers 1
Jing Cheng
Co-authored papers 1
Jia Liu
Co-authored papers 1
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Co-authored papers 1
Release 1.2